Effect of tesaglitazar, a dual PPARα/γ agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12-week dose-ranging trial

By Goldstein Barry J.   Rosenstock Julio   Anzalone Deborah   Tou Conrad   Öhman K. Peter  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2575-2590

Informa Healthcare

Access to resources Recommend Favorite

Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study

By Wenying Yang   Benroubi Marian   Borzi Vito   Gumprecht Janusz   Kawamori Ryuzo   Shaban Joseph   Shah Siddharth   Shestakova Marina   Ligthelm Robert   Valensi Paul  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2643-2654

Informa Healthcare

Access to resources Recommend Favorite

Effect of 12-Week Tai Chi Chuan Exercise on Peripheral Nerve Modulation in Patients with Type 2 Diabetes Mellitus

By Hung Jen-Wen   Liou Chia-Wei   Wang Pei-Wen   Yeh Shu-Hui   Lin Li-Wei   Lo Sing-Kai   Tsai Fu-Mian  

Journal of Rehabilitation Medicine, Vol. 41, Iss. 11, 2009-10 ,pp. : 924-929

Medical Journals Limited

Access to resources Recommend Favorite

Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 20, Iss. 1, 2018-01 ,pp. : 136-147

John Wiley & Sons Inc

Access to resources Recommend Favorite

Weight‐neutral effect of insulin detemir

By  

JOURNAL OF DIABETES, Vol. 7, Iss. 2, 2015-03 ,pp. : 222-230

John Wiley & Sons Inc

Access to resources Recommend Favorite